Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Consultants in Medical Oncology and Hematology?Newtown Square
mi
from
Newtown Square, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Lakeland Hospital Niles
mi
from
Niles, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago Medicine-Orland Park
mi
from
Orland Park, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Geisinger Cancer Services-Pottsville
mi
from
Pottsville, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Cancer Center - Rocklin
mi
from
Rocklin, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
CHRISTUS Highland Medical Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Epic Care Cyberknife Center
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of West Branch
mi
from
West Branch, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Lakes Medical Center
mi
from
Wyoming, MN
Click here to add this to my saved trials
Clinical Trial
VX-970 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
ThedaCare Regional Cancer Center
mi
from
Appleton, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Waldo County General Hospital
mi
from
Belfast, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Joe Lueken Cancer Center
mi
from
Bemidji, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford
mi
from
Biddeford, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
UCHealth Memorial Hospital Central
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Iowa Cancer Specialists, PC
mi
from
Davenport, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Beaumont Hospital - Farmington Hills
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-Kuakini
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Center of The South Incorporated
mi
from
Houma, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Regional Cancer Center at Indian Path Community Hospital
mi
from
Kingsport, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
OptumCare Cancer Care at Oakey
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
UH Seidman Cancer Center at Lake Health Mentor Campus
mi
from
Mentor, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Franciscan Health Mooresville
mi
from
Mooresville, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
AMG Oncology - Naperville
mi
from
Naperville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Regional Cancer Center
mi
from
Redding, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Desoto
mi
from
Southhaven, MS
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Promedica Flower Hospital
mi
from
Sylvania, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cotton O'Neil Cancer Center / Stormont Vail Health
mi
from
Topeka, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Gene Upshaw Memorial Tahoe Forest Cancer Center
mi
from
Truckee, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Woodland Memorial Hospital
mi
from
Woodland, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Wright-Patterson Medical Center
mi
from
Wright-Patterson Air Force Base, OH
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Tom Baker Cancer Centre
mi
from
Calgary,
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Rex Hematology Oncology Associates-Garner
mi
from
Garner, NC
Click here to add this to my saved trials
Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Saint Mary's
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Status: Enrolling, Phase IV
Updated: 2/6/2018
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Commack, NY
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Englewood, NJ
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Morristown, NJ
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Olympia, WA
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Lymphoma,Non-Hodgkin Clinical Trial
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
Influenza Clinical Trial
Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza
Status: Enrolling, Phase III
Updated: 12/31/1969
Peramivir investigative site
mi
from
South Jordan, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
B-Cell Chronic Lymphocytic Leukemia Clinical Trial
Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy
Status: Enrolling, Phase I
Updated: 8/16/2016
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
B-Cell Chronic Lymphocytic Leukemia Clinical Trial
Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy
Status: Enrolling, Phase I
Updated: 8/16/2016
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Infection in Solid Organ Transplant Recipients Clinical Trial
T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays
Status: Enrolling
Updated: 6/20/2016
SUNY
mi
from
Syracuse, NY
Click here to add this to my saved trials
Infection in Solid Organ Transplant Recipients Clinical Trial
T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays
Status: Enrolling
Updated: 6/20/2016
University Health Network
mi
from
Toronto,
Click here to add this to my saved trials
Open Abdomen Procedure Clinical Trial
International Register of Open Abdomen
Status: Enrolling
Updated: 1/25/2017
Letterkenny Surgery dept. Letterkenny Hospital
mi
from
Letterkenny,
Click here to add this to my saved trials
Oncology Clinical Trial
INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
Status: Enrolling, Phase I
Updated: 12/31/1969
HCA Midwest - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Status: Enrolling, Phase II
Updated: 4/30/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases, Other Clinical Trial
Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007)
Status: Enrolling, Phase I
Updated: 6/13/2017
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases, Other Clinical Trial
Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007)
Status: Enrolling, Phase I
Updated: 6/13/2017
Clinical Research Facility
mi
from
Hazard, KY
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases, Other Clinical Trial
Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007)
Status: Enrolling, Phase I
Updated: 6/13/2017
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
Oral Anticoagulation Therapy Pilot Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
Le Centre Hospitalier de Bordeaux
mi
from
Bordeaux,
Click here to add this to my saved trials
Bone Cyst Clinical Trial
Simple Bone Cysts in Kids
Status: Enrolling, Phase III
Updated: 12/31/1969
Alberta Children's Hospital
mi
from
Calgary,
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
McKinney, TX
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Westerville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)
Status: Enrolling, Phase II
Updated: 6/1/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)
Status: Enrolling, Phase II
Updated: 6/1/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)
Status: Enrolling, Phase II
Updated: 6/1/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)
Status: Enrolling, Phase II
Updated: 6/1/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Niles, IL
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Hospital - Muhleberg
mi
from
Bethlehem, PA
Click here to add this to my saved trials